Ketorolac 0.5% w/v


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Side effects of Oxikit Eye Drop The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Oxikit Nausea Burning sensation Stinging sensation Vomiting Stomach pain/epigastric pain Indigestion Diarrhea Heartburn Loss of appetite
How to use Oxikit Eye Drop This medication is designated for external application solely. Utilize it according to the dosage and duration instructed by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
How Oxikit Eye Drop works Oxikit 0.5% Eye Drop is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
No interaction has been found or established.
Oxikit 0.5% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Oxikit 0.5% Eye Drop is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Oxikit 0.5% Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
No interaction found/established
No interaction found/established
If you forget a dose of Oxikit 0.5% Eye Drop , simply continue with your regular schedule and do not take a double dose.
SCF 48 & 51, New Grain Market, Sector 20, Panchkula-134116, Haryana, India
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 628
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 986
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 760-62
Ketorolac. Marlow, Bucks: Allergan Ltd.; 2006 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Ketorolac tromethamine ophthalmic solution (20 Feb. 2024)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.